Raw material and freight cost escalation
Geopolitical tensions in West Asia have increased raw material, packaging, and freight costs; management noted uncertainty in passing these on to customers.
GRANULESINDIA / Q4-FY26 / risks
Keep the risk register visible.
Granules India · Material risks, their source context, and severity in the latest available quarter.
Research layer active
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Risk intelligence
Material risks this quarter
high
Gagilapur FDA reinspection timeline uncertainty
Despite completing remediation, the FDA has not scheduled a reinspection; management cannot estimate when it will occur, delaying potential product launches.
Peptide CDMO customer concentration and project dependency
The peptide CDMO business is project-driven with potential quarter-to-quarter volatility; management declined to disclose order book or customer concentration details.
DCDA project commercialization delays
The DCDA pilot plant faced pricing pressure from Chinese competitors; commercialization may be delayed by 2-3 months, with capex of ~₹200 crore.